SGCB and hydrops fetalis: The nitric oxide (NO)—soluble guanylate cyclase (sGC)—cyclic guanosine monophosphate (cGMP) pathway is a subject of scientific interest as it might be a potential therapeutic target for patients with symptomatic HF.